Trial Profile
An Open Label Multi Center Phase III Subject/Caregiver Initiated Safety Study of Xerese(Acyclovir and Hydrocortisone)Cream 5%/1% in the Treatment of Recurrent Herpes Labialis in Children
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Aciclovir/hydrocortisone (Primary)
- Indications Herpes labialis
- Focus Adverse reactions; Registrational
- Sponsors Meda Pharmaceuticals
- 01 Feb 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 19 Apr 2012 New trial record